Skip to main content

Table 1 Baseline and preoperative characteristics

From: Effect of preoperative pulmonary artery pressure on the prognosis of end-stage heart failure patients after heart transplantation

Variable

mPAP < 30.5mmHg

(n = 66)

mPAP ≥ 30.5mmHg

(n = 39)

P value

Men(%)

50(75.8)

35(89.7)

0.815

Age(years)

48 ± 14.6

50 ± 12.3

0.550

Recipient weight(Kg)

64 ± 11.8

72 ± 13.4

0.015

Weight of donor(Kg)

70 ± 10.4

71 ± 10.8

0.340

Body weight ratio (donor/recipient)

1.1 ± 0.26

1.0 ± 0.16

0.011

Diabetes(%)

4(6.1)

3(7.7)

1.000

Hypertension(%)

4(6.1)

6(15.4)

0.219

Stroke(%)

0

1(2.6)

0.371

Previous surgical history

   

Valve surgery(%)

4(6.1)

2(5.1)

1.000

Coronary intervention(%)

0

7(17.9)

0.001

ICD(%)

3(4.5)

4(10.3)

0.466

Congenital heart disease surgery(%)

2(3.0)

0

0.529

Coronary artery bypass grafting(%)

1(1.5)

0

1.000

Left ventricular assist device(%)

1(1.5)

0

1.000

Transcatheter radiofrequency ablation(%)

1(1.5)

0

1.000

Cause

   

Dilated cardiomyopathy(%)

51(77.3)

28(71.8)

0.530

Ischemic cardiomyopathy(%)

4(6.1)

5(12.8)

0.404

Valvular heart disease(%)

7(10.6)

5(12.8)

0.730

Congenital heart disease(%)

1(1.5)

0

1.000

Restrictive cardiomyopathy(%)

1(1.5)

1(2.6)

1.000

Heart tumor(%)

1(1.5)

0

1.000

Myocardial amyloidosis(%)

1(1.5)

0

1.000

Waiting Time(day)

67 ± 124.4

81 ± 98.9

0.011

Mean pulmonary artery pressure(mmHg)

21 ± 5.4

39 ± 6.5

0.000

Laboratory examination

   

Hemoglobin(g/L)

124 ± 10.4

126 ± 9.6

0.230

Creatinine(µmoI/L)

88 ± 15.4

92 ± 13.8

0.451

pro-NBP(ng/L)

286 ± 138.2

298 ± 134.6

0.466

Leukocyte(109/L)

8.9 ± 2.4

8.6 ± 3.4

0.364

  1. ICD: Implantable cardioverter defibrillator